NASOPHARYNGEAL CARCINOMA (NPC)
Clinical trials for NASOPHARYNGEAL CARCINOMA (NPC) explained in plain language.
Never miss a new study
Get alerted when new NASOPHARYNGEAL CARCINOMA (NPC) trials appear
Sign up with your email to follow new studies for NASOPHARYNGEAL CARCINOMA (NPC), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for Tough-to-Treat nasopharyngeal cancer: targeted drug trial launches
Disease control Recruiting nowThis study tests a new drug called HLX43 in 70 people with advanced nasopharyngeal cancer that has come back or spread and did not respond to or could not tolerate standard second-line treatments. The drug is designed to target and attack cancer cells while sparing healthy ones. …
Matched conditions: NASOPHARYNGEAL CARCINOMA (NPC)
Phase: PHASE2 • Sponsor: Shanghai Henlius Biotech • Aim: Disease control
Last updated May 26, 2026 05:58 UTC
-
Smarter radiation for throat cancer aims to cut side effects without sacrificing cure
Disease control Recruiting nowThis study tests whether giving radiation only to the parts of the neck where cancer has spread (instead of the whole neck) can prevent cancer from coming back while causing fewer side effects. About 462 adults with nasopharyngeal cancer will be randomly assigned to standard or p…
Matched conditions: NASOPHARYNGEAL CARCINOMA (NPC)
Phase: PHASE3 • Sponsor: Fudan University • Aim: Disease control
Last updated May 26, 2026 05:57 UTC
-
Proton therapy may offer safer, more effective treatment for advanced throat cancer
Disease control Recruiting nowThis study compares two types of radiation therapy—proton therapy and standard photon therapy—for people with advanced nasopharyngeal cancer. All participants receive chemotherapy and immunotherapy alongside radiation. The goal is to see if proton therapy causes fewer severe side…
Matched conditions: NASOPHARYNGEAL CARCINOMA (NPC)
Phase: PHASE3 • Sponsor: Man Hu • Aim: Disease control
Last updated May 26, 2026 04:37 UTC
-
New combo therapy shows promise for returning throat cancer
Disease control Recruiting nowThis study tests a new treatment for nasopharyngeal cancer that has come back after initial therapy and cannot be surgically removed. The approach uses a special pattern of low and high dose radiation together with an immunotherapy drug (anti-PD-1) to shrink tumors, followed by s…
Matched conditions: NASOPHARYNGEAL CARCINOMA (NPC)
Phase: PHASE2 • Sponsor: Jiangxi Provincial Cancer Hospital • Aim: Disease control
Last updated May 26, 2026 04:37 UTC
-
Could less radiation be enough for some advanced head and neck cancers?
Disease control Recruiting nowThis study is for people with advanced nasopharyngeal cancer (a type of head and neck cancer) whose tumors shrink significantly after initial chemotherapy and immunotherapy. It tests whether a lower dose of radiation therapy is as effective as the standard dose, with fewer side e…
Matched conditions: NASOPHARYNGEAL CARCINOMA (NPC)
Phase: PHASE3 • Sponsor: Ming-Yuan Chen • Aim: Disease control
Last updated May 22, 2026 13:54 UTC
-
New combo therapy aims to improve survival in advanced nose cancer
Disease control Recruiting nowThis phase 3 trial tests whether a new drug called Becotatug vedotin, combined with immunotherapy (sintilimab) and standard chemoradiotherapy, works better than current standard treatment for people with high-risk nasopharyngeal carcinoma. The study plans to enroll 266 adults age…
Matched conditions: NASOPHARYNGEAL CARCINOMA (NPC)
Phase: PHASE3 • Sponsor: First Affiliated Hospital of Guangxi Medical University • Aim: Disease control
Last updated May 22, 2026 13:50 UTC
-
Could less radiation be just as good for advanced nasopharyngeal cancer?
Disease control Recruiting nowThis study is for people with nasopharyngeal cancer that has spread to other parts of the body. It compares two radiation approaches after full chemotherapy and immunotherapy: one that treats a smaller area and one that treats the standard larger area. The goal is to see if the s…
Matched conditions: NASOPHARYNGEAL CARCINOMA (NPC)
Phase: PHASE3 • Sponsor: Ming-Yuan Chen • Aim: Disease control
Last updated May 22, 2026 13:50 UTC
-
Double immune attack: new combo therapy targets hard-to-treat nose and throat cancer
Disease control Recruiting nowThis study tests a combination of two immune-boosting drugs (iparomlimab and tuvonralimab) plus a targeted antibody (nimotuzumab) in 41 adults with recurrent or metastatic nasopharyngeal carcinoma that worsened after standard first-line chemotherapy. The goal is to see if this tr…
Matched conditions: NASOPHARYNGEAL CARCINOMA (NPC)
Phase: PHASE2 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated May 11, 2026 20:52 UTC
-
Could a simple inhaler ease chemo mouth pain for cancer patients?
Symptom relief Recruiting nowThis study tests if a drug called Sapylin, given through an inhaler, can prevent or reduce painful mouth sores caused by chemotherapy and radiation in people with nasopharyngeal cancer. About 180 adults will be randomly assigned to receive either Sapylin or the standard treatment…
Matched conditions: NASOPHARYNGEAL CARCINOMA (NPC)
Phase: PHASE3 • Sponsor: Affiliated Hospital of Guangdong Medical University • Aim: Symptom relief
Last updated May 22, 2026 13:52 UTC
-
New PET scan could help doctors choose the right therapy for nasopharyngeal cancer
Knowledge-focused Recruiting nowThis study tests whether a special PET scan can show a specific protein (SSTR2) on nasopharyngeal cancer cells. Ten adults with EBV-related nasopharyngeal cancer will get the scan before and early after starting chemotherapy or chemoradiation. The goal is to see if this imaging m…
Matched conditions: NASOPHARYNGEAL CARCINOMA (NPC)
Phase: PHASE1, PHASE2 • Sponsor: University Medical Center Groningen • Aim: Knowledge-focused
Last updated May 26, 2026 05:51 UTC